Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GLMD Galmed Pharmaceuticals Ltd

0.00 (0.0%)
Pre Market
Last Updated: 04:43:18
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.3852
Ask Price 0.4299
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Galmed Pharmaceuticals Ltd GLMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.395 04:43:18
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 0.26 - 14.175
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.395 USD

Galmed Pharmaceuticals Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
655.2k 1.68M - 0 -17.87M -10.63 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Galmed Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No GLMD Message Board. Create One! See More Posts on GLMD Message Board See More Message Board Posts

Historical GLMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.35570.41740.32060.3727879104,7120.039311.05%
1 Month0.400.43430.260.3870169397,927-0.005-1.25%
3 Months0.770.87490.260.429632190,526-0.375-48.7%
6 Months4.305.470.261.31227,535-3.91-90.81%
1 Year4.57514.1750.263.80208,968-4.18-91.37%
3 Years55.3593.750.2629.07189,765-54.96-99.29%
5 Years127.20146.100.2643.12150,424-126.81-99.69%

Galmed Pharmaceuticals Description

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Your Recent History

Delayed Upgrade Clock